Unavailable
Unavailable
Save time and jump to the most important pieces.
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
425 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
DEFM14A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Filer)
8-K - SUNLINK HEALTH SYSTEMS INC (0000096793) (Filer)
SunLink Health Systems, Inc. (NYSE:SSY) today announced a loss from continuing operations of $630,000 (or a loss of $0.09 per fully diluted share) for its third fiscal quarter ended March 31, 2025 compared to a loss from continuing operations of $824,000 (or a loss of $0.12 per fully diluted share) for the third fiscal quarter ended March 31, 2025. Net loss for the quarter ended March 31, 2025 was $671,000 (or a loss of $0.10 per fully diluted share) compared to a net loss of $1,396,000 (or a loss of $0.20 per fully diluted share) for the quarter ended March 31, 2024. Loss from discontinued operations was $41,000 (or a loss of $01 per fully diluted share)for the quarter ended March 31, 202
Atlanta, GA, April 15, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. ("Regional") (OTCQB:RHEP) (OTCQB:RHEPA) and SunLink Health Systems, Inc. ("SunLink") (NYSE:SSY) jointly announced today that they have entered into an amended and restated agreement and plan of merger (the "merger agreement"), pursuant to which SunLink will merge with and into Regional (the "merger") in exchange for the issuance of an aggregate of approximately 1,595,401 shares of Regional common stock and 1,408,121 shares of Regional's newly-authorized Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Regional Series D Preferred Stock") with an initial liquidation preference o
SunLink Health Systems, Inc. (NYSE:SSY) today announced a loss from continuing operations of $1,070,000 (or a loss of $0.15 per fully diluted share) for its second fiscal quarter ended December 31, 2024 compared to a loss from continuing operations of $407,000 (or a loss of $0.06 per fully diluted share) for the second fiscal quarter ended December 31, 2023. During the quarter ended December 31, 2024, the Company recorded an impairment loss of $100,000 to write down the value of the net assets of its information technology business which sold in January 2025. Net loss for the quarter ended December 31, 2024 was $1,343,000 (or a loss of $0.19 per fully diluted share) compared to a net loss
SC 13D/A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
SC 13D/A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
SC 13D/A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
Atlanta, GA, April 15, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. ("Regional") (OTCQB:RHEP) (OTCQB:RHEPA) and SunLink Health Systems, Inc. ("SunLink") (NYSE:SSY) jointly announced today that they have entered into an amended and restated agreement and plan of merger (the "merger agreement"), pursuant to which SunLink will merge with and into Regional (the "merger") in exchange for the issuance of an aggregate of approximately 1,595,401 shares of Regional common stock and 1,408,121 shares of Regional's newly-authorized Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Regional Series D Preferred Stock") with an initial liquidation preference o
Enhances Opportunity to Increase Shareholder Value Significantly Strengthens Balance Sheet Expands Regional Board with the Addition of Two Highly Qualified Industry Veterans Atlanta, GA, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. ("Regional") (NYSE:RHE) (NYSE:RHE) and SunLink Health Systems, Inc. ("SunLink") (NYSE:SSY) jointly announced today that they have entered into a definitive agreement and plan of merger (the "merger agreement"), pursuant to which SunLink will merge with and into Regional (the "merger") in exchange for the issuance of an aggregate of 1,410,000 shares of Regional common stock and 1,410,000 shares of Regional's newly-authorized Series D 8% C
SunLink Health Systems, Inc. (NYSE:SSY) today announced that its Board of Directors (a) declared a dividend of one one-thousandth (1/1,000th) of a share (each a "Series C Fractional Interest") of the Company's newly-designated Series C Redeemable Preferred Shares, no par value per share (the "Series C Preferred Shares"), for each outstanding common share of the Company (the "Common Shares"), payable on August 16, 2023 to shareholders of record as of 5:00 p.m. Eastern Time on August 15, 2023 and (b) its intent to call a special meeting of shareholders to consider and approve a proposal to reincorporate the Company as a Georgia corporation (the "Reincorporation Proposal"). The outstanding S